XML 98 R87.htm IDEA: XBRL DOCUMENT
v3.25.2

LEGAL PROCEEDINGS - Intellectual Property (Details) |  |  |  |  |  |  |  |  |  |  | 1 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Apr. 10, 2025 proceeding | Apr. 04, 2025 | Mar. 28, 2025 | Mar. 26, 2025 | Feb. 05, 2025 | Nov. 01, 2024 | Sep. 27, 2024 | Apr. 05, 2024 | Sep. 10, 2021 | Feb. 17, 2020 | Mar. 31, 2021 proceeding defendant
Norwich I Xifaxan Litigation |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  |  |  |  |  |  |  |  |  | 30 months |
Amneal Xifaxan Litigation |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of approval, period |  |  |  |  |  |  |  | 30 months |  |  |
Zydus Xifaxan Litigation |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of approval, period |  |  |  |  |  |  | 30 months |  |  |  |
Cipla Anticipated Xifaxan Litigation |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  |  |  |  |  | 30 months |  |  |  |  |
Mylan Anticipated Xifaxan Litigation |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  |  |  | 30 months |  |  |  |  |  |  |
SABA Anticipated Xifaxan Litigation |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  | 30 months |  |  |  |  |  |  |  |  |
Alkem Xifaxan Litigation |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  | 30 months |  |  |  |  |  |  |  |  |
The Anticipated Cabtreo Paragraph IV Proceedings |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  |  |  |  | 30 months |  |  |  |  |  |
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of defendants | defendant |  |  |  |  |  |  |  |  |  |  | 20
Number of proceedings |  |  |  |  |  |  |  |  |  |  | 17
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of defendants | 15 |  |  |  |  |  |  |  |  |  |
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of defendants | 2 |  |  |  |  |  |  |  |  |  |
Lumify Paragraph I V Proceedings Slayback ANDA Litigation | Bausch + Lomb |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  |  |  |  |  |  |  |  | 30 months |  |
Lumify Paragraph I V Proceedings Somerset ANDA Litigation | Bausch + Lomb |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  |  | 30 months |  |  |  |  |  |  |  |
Lumify Paragraph I V Proceedings Gland ANDA Litigation | Bausch + Lomb |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Stay of the approval, period |  |  | 30 months |  |  |  |  |  |  |  |

X
- Definition Gain Contingency, Number Of Defendants + References No definition available. + Details
Name: | bhc_GainContingencyNumberOfDefendants
Namespace Prefix: | bhc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gain Contingency, Number Of Proceedings + References No definition available. + Details
Name: | bhc_GainContingencyNumberOfProceedings
Namespace Prefix: | bhc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gain Contingency, Stay Of Approval, Period + References No definition available. + Details
Name: | bhc_GainContingencyStayOfApprovalPeriod
Namespace Prefix: | bhc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Stay Of Approval, Period + References No definition available. + Details
Name: | bhc_LossContingencyStayOfApprovalPeriod
Namespace Prefix: | bhc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 27 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1 + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=bhc_NorwichIXifaxanLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_AmnealXifaxanLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_ZydusXifaxanLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_CiplaAnticipatedXifaxanLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_MylanAnticipatedXifaxanLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_SABAAnticipatedXifaxanLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_AlkemXifaxanLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_TheAnticipatedCabtreoParagraphIVProceedingsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_PreserVisionAREDSPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=bhc_BauschLombMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=bhc_DefaultJudgementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_LumifyParagraphIVProceedingsSlaybackANDALitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_LumifyParagraphIVProceedingsSomersetANDALitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_LumifyParagraphIVProceedingsGlandANDALitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |